$HWM

Howmet Aerospace retreats 8% after SpaceX in-house turbine plan (HWM:NYSE)

Howmet Aerospace (HWM) shares fell 8% to $244.95 after SpaceX announced plans to produce its own turbine blades, raising concerns about demand for Howmet's specialized components. Analysts note high valuation multiples may limit upside potential.

Original reporting
Published Aug 31, 2026, 8:51 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 1, 2026, 1:44 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefMarket movers
Primary signal
$HWM
Bearish
medium confidence
Mentioned
$HWM
Relevance
7/10
alphai data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$HWMBearishMed
01

Why it matters

The announcement could shave revenue from aerospace contracts, prompting a re‑rating by analysts.

02

Market read

The news directly links a major customer’s vertical integration to a sharp stock decline for its supplier.

03

What to watch

Howmet's diversified industrial turbine business could offset aerospace losses.

Relevance 7/10Novelty 7/10Timing: pre‑market Monday

Background

Howmet Aerospace is a leading supplier of high‑temperature turbine components for aerospace and industrial markets.

Company-level read

Ticker impact

$HWMBearishMedium confidence
Context

Howmet Aerospace shares fell ~8% after SpaceX announced it will produce its own gas turbine blades, threatening demand for Howmet's components.

Expected impact

Further downside pressure expected if SpaceX proceeds with internal production.

Evidence & confidence

A major aerospace customer moving to self‑supply cuts a key revenue stream for Howmet.

Market effects

Potential ripple effect on other turbine component suppliers and aerospace OEMs.

U.S. aerospace sector may see modest sell‑off.

Highlights trend of vertical integration in space launch industry.

Counterpoint

SpaceX may still need external suppliers for specialized alloys, limiting impact on Howmet.

Key entities

  • SpaceX

    Aerospace launch provider planning in‑house turbine blade production.

  • Howmet Aerospace

    Supplier of specialized turbine components.

Related articles

$HWMMed

HWM Looks 55.7% Overvalued on GF Value™ Amid Strong Growth Prosp

Deutsche Bank analyst Scott Deuschle highlighted Howmet Aerospace Inc (HWM) as a top pick, citing its unique business model and strong growth prospects. The firm set a $34.3 target price, anticipating robust earnings growth through 2029. However, GuruFocus' GF Value™ metric indicates HWM is 55.7% overvalued, trading at $254.89 vs. an intrinsic value estimate of $163.75. The company's GF Score™ is 87/100, reflecting strong financial health and operational momentum, but valuation concerns persist.

$HWMMed

Citi Says 'Buy the Dip' on Howmet Stock After SpaceX Turbine Move

Howmet Aerospace (HWM) shares fell after SpaceX announced plans to produce some gas-turbine components internally. Citi maintained a Buy rating, citing strong demand in the industrial gas-turbine market. Bernstein raised its price target to $328. Analysts see potential long-term support from AI data center power needs.

$HWMHigh

Howmet Aerospace stock rises amid analyst buying opportunity call

Howmet Aerospace Inc. (NYSE:HWM) shares rose 3.3% after analysts called recent weakness a buying opportunity. Bernstein SocGen's Douglas Harned maintained an Outperform rating and $328 price target, noting SpaceX's plans to build turbine parts won't threaten Howmet's market position. Citi's John Godyn reiterated a Buy rating and $329 target, adding a 30-Day Upside catalyst watch.

$HWMMed

One aerospace stock got hit by a SpaceX announcement. Two analysts say buy the dip

Howmet Aerospace (HWM) fell 8% after SpaceX announced plans to produce its own industrial gas turbine castings. Citigroup and Bernstein reiterated buy ratings, citing Howmet's market dominance and long-term agreements, with price targets of $329 and $328 respectively, implying ~34% upside. Howmet is down 13% in a month but up 19.5% YTD and 41% over the past year.